Runben Biotechnology Co Ltd
SSE:603193
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Runben Biotechnology Co Ltd
SSE:603193
|
CN |
|
E
|
Electrocomponents PLC
LSE:ECM
|
UK |
|
C
|
China Satellite Communications Co Ltd
SSE:601698
|
CN |
|
Carvana Co
NYSE:CVNA
|
US |
|
Unity Bancorp Inc
NASDAQ:UNTY
|
US |
|
Yamada Holdings Co Ltd
TSE:9831
|
JP |
Wall St Price Targets
Price Targets Summary
Runben Biotechnology Co Ltd
According to Wall Street analysts, the average 1-year price target for Runben Biotechnology Co Ltd is 35.16 CNY with a low forecast of 32.87 CNY and a high forecast of 38.22 CNY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Runben Biotechnology Co Ltd's stock price target?
Price Target
35.16
CNY
According to Wall Street analysts, the average 1-year price target for Runben Biotechnology Co Ltd is 35.16 CNY with a low forecast of 32.87 CNY and a high forecast of 38.22 CNY.
What is the Revenue forecast for Runben Biotechnology Co Ltd?
Projected CAGR
19%
Over the last 1 year, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 4 years is 19%.
What is the Operating Income forecast for Runben Biotechnology Co Ltd?
Projected CAGR
21%
Over the last 1 year, the compound annual growth rate for Operating Income has been 25%. The projected CAGR for the next 3 years is 21%.
What is the Net Income forecast for Runben Biotechnology Co Ltd?
Projected CAGR
15%
Over the last 1 year, the compound annual growth rate for Net Income has been 33%. The projected CAGR for the next 4 years is 15%.
